Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...

Get Instant Summarized Text (Gist) Tirzepatide, a dual-incretin, was evaluated for its effects on cardiovascular and kidney biomarkers in overweight and obese adults with type 1 diabetes. Over 21 ...

Tirzepatide may be more effective than semaglutide or liraglutide for weight loss, as it has a dual mechanism of action.

GLP-1s like semaglutide and tirzepatide show promising MASH ... Madrigal believes that Rezdiffra's “fast” onset and “liver-directed” mechanism differentiates it from GLP-1s.